Aliphatic amide and ester pyrazinoylguanidine sodium channel...

Details Aliphatic amide and ester pyrazinoylguanidine sodium channel... Aliphatic amide and ester pyrazinoylguanidine sodium channel...

2011-06-07

2011-06-07

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S357000, C544S386000

Reexamination Certificate

active

07956059

ABSTRACT:
The present invention relates to pyrazinoylguanidine compounds represented by formula (I):where the structural variables are defined herein. The compounds are useful as, for example, sodium channel blockers.

REFERENCES:
patent: 6264975 (2001-07-01), Boucher, Jr.
patent: 6858614 (2005-02-01), Johnson
patent: 6858615 (2005-02-01), Johnson
patent: 6903105 (2005-06-01), Johnson
patent: 6995160 (2006-02-01), Johnson
patent: 7026325 (2006-04-01), Johnson
patent: 7030117 (2006-04-01), Johnson
patent: 7064129 (2006-06-01), Johnson et al.
patent: 7186833 (2007-03-01), Johnson
patent: 7189719 (2007-03-01), Johnson
patent: 7192958 (2007-03-01), Johnson
patent: 7192959 (2007-03-01), Johnson
patent: 7192960 (2007-03-01), Johnson
patent: 2004/0198744 (2004-10-01), Johnson
patent: 2004/0198747 (2004-10-01), Johnson
patent: 2004/0198749 (2004-10-01), Johnson
patent: 2004/0204424 (2004-10-01), Johnson
patent: 2005/0059676 (2005-03-01), Johnson
patent: 2005/0080092 (2005-04-01), Johnson
patent: 2005/0080093 (2005-04-01), Johnson et al.
patent: 2005/0090505 (2005-04-01), Johnson et al.
patent: 2005/0228182 (2005-10-01), Johnson et al.
patent: 2005/0234072 (2005-10-01), Johnson et al.
patent: 2006/0040954 (2006-02-01), Johnson
patent: 2006/0052394 (2006-03-01), Johnson et al.
patent: 2006/0052395 (2006-03-01), Johnson et al.
patent: 2006/0063780 (2006-03-01), Johnson
patent: 2006/0142306 (2006-06-01), Johnson
patent: 2006/0142581 (2006-06-01), Johnson
patent: 2006/0205738 (2006-09-01), Johnson et al.
patent: 2007/0032509 (2007-02-01), Johnson et al.
patent: WO 03/070182 (2003-08-01), None
patent: WO 03/070182 (2003-08-01), None
patent: WO 03/070184 (2003-08-01), None
patent: WO 03/070184 (2003-08-01), None
patent: WO 2004/073629 (2004-09-01), None
patent: WO 2004/073629 (2004-09-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, 205.
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Hackam, et al. JAMA, 296(14), 2006, 1731-1732.
Thomas R. Kleyman, et al., “New Amiloride Analogue as Hapten to Raise Anti-Amiloride Antibodies”, American Journal of Physiology, vol. 250, pp. C165-0170, 1986.
U.S. Appl. No. 10/920,527, filed Aug. 18, 2004, Hopkins.
U.S. Appl. No. 11/573,693, filed Feb. 14, 2007, Johnson.
U.S. Appl. No. 11/573,421, filed Feb. 8, 2007, Johnson.
U.S. Appl. No. 11/695,936, filed Apr. 3, 2007, Johnson.
U.S. Appl. No. 11/696,003, filed Apr. 3, 2007, Johnson.
U.S. Appl. No. 11/852,003, filed Sep. 7, 2007, Johnson, et al.
U.S. Appl. No. 11/851,803, filed Sep. 7, 2007, Johnson, et al.
U.S. Appl. No. 11/960,989, filed Dec. 20, 2007, Johnson, et al.
U.S. Appl. No. 11/950,674, filed Dec. 5, 2007, Johnson, et al.
U.S. Appl. No. 11/835,902, filed Aug. 8, 2007, Johnson, et al.
U.S. Appl. No. 12/049,946, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/049,968, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/049,894, filed Mar. 17, 2008, Johnson, et al.
U.S. Appl. No. 12/050,010, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/049,993, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/050,019, filed Mar. 17, 2008, Johnson.
U.S. Appl. No. 12/061,837, filed Apr. 3, 2008, Johnson, et al.
U.S. Appl. No. 12/061,864, filed Apr. 3, 2008, Johnson, et al.
U.S. Appl. No. 12/098,581, filed Apr. 7, 2008, Johnson.
U.S. Appl. No. 60/495,725, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/495,720, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 06/495,712, filed Aug. 18, 2003, Johnson.
U.S. Appl. No. 60/602,312, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 60/602,327, filed Aug. 18, 2004, Johnson.
U.S. Appl. No. 60/812,091, filed Jun. 9, 2006, Johnson.
U.S. Appl. No. 60/812,077, filed Jun. 9, 2006, Johnson, et al.
U.S. Appl. No. 60/812,078, filed Jun. 9, 2006, Johnson.
U.S. Appl. No. 60/842,669, filed Sep. 7, 2006, Johnson, et al.
U.S. Appl. No. 60/842,963, filed Sep. 8, 2006, Johnson, et al.
U.S. Appl. No. 60/845,171, filed Sep. 18, 2006, Johnson, et al.
U.S. Appl. No. 60/909,818, filed Apr. 3, 2007, Johnson, et al.
U.S. Appl. No. 60/978,887, filed Oct. 10, 2007, Boucher, et al.
U.S. Appl. No. 60/978,874, filed Oct. 10, 2007, Boucher, et al.
U.S. Appl. No. 60/987,663, filed Nov. 13, 2007, Johnson, et al.
U.S. Appl. No. 61/013,387, filed Dec. 13, 2007, Johnson, et al.
U.S. Appl. No. 61/030,313, filed Feb. 21, 2008, Johnson.
U.S. Appl. No. 61/031,466, filed Feb. 26, 2008, Johnson.
U.S. Appl. No. 12/171,814, filed Jul. 11, 2008, Johnson, et al.
U.S. Appl. No. 12/171,867, filed Jul. 11, 2008, Johnson, et al.
U.S. Appl. No. 12/171,897, filed Jul. 11, 2008, Johnson, et al.
U.S. Appl. No. 12/190,022, filed Aug. 12, 2008, Johnson.
U.S. Appl. No. 61/079,989, filed Jul. 11, 2008, Boucher, et al.
U.S. Appl. No. 12/179,353, filed Jul. 24, 2008, Johnson.
U.S. Appl. No. 12/249,175, filed Oct. 10, 2008, Boucher, et al.
U.S. Appl. No. 12/304,006, filed Dec. 9, 2008, Johnson, et al.
U.S. Appl. No. 12/304,042, filed Dec. 9, 2008, Johnson.
U.S. Appl. No. 12/304,040, filed Dec. 9, 2008, Johnson.
U.S. Appl. No. 12/393,252, filed Feb. 26, 2009, Johnson.
U.S. Appl. No. 60/909,802, filed Apr. 3, 2007, Johnson, et al.
U.S. Appl. No. 12/501,654, filed Jul. 13, 2009, Boucher, et al.
U.S. Appl. No. 12/876,615, filed Sep. 7, 2010, Johnson, et al.

Affiliated with

Also associated with

Rating

Aliphatic amide and ester pyrazinoylguanidine sodium channel... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aliphatic amide and ester pyrazinoylguanidine sodium channel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aliphatic amide and ester pyrazinoylguanidine sodium channel... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2667914